Elastic shape-memory polymers as self-expendable polymeric drug-eluting stents are developed for the first time, with good mechanical properties, fast self-expansion, and sustained drug release. Novel star block co-polymer PCTOPDs containing hyperbranched poly(ε-caprolactone) (PCL) switching segment and poly(2-oxepane-1,5-dione) (POPD) hard segment were synthesized in high yield and characterized by NMR, GPC, DSC, tensile test and cyclic thermomechanical tensile test. PCTOPD containing 15–27 wt% POPD (PCTOPD-15–27) are found to be non-cytotoxic thermoplastic elastomers (Tm of 39–40 and 120–129 °C, εb of 908–1060%, σm of 12–20 MPa, and E of 60–91 MPa) with good shape-memory properties at 40 °C (Rf of 95–97%, Rr of 97–99%, and shape recovery time of 35 s). The stent made from PCTOPD-27 gives nearly full self-expansion at 37 °C within 45 s. The collapse pressure at a compressive strain of 30% is 1.7 bar. A stent containing 3.0 wt% paclitaxel releases 42% drug linearly in the first 9 days and 67% drug in 30 days with a slower but nearly linear release for the period of 10–30 days. The developed SMP-based drug-eluting stents might be useful in biomedical application such as the treatment of coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: